Warning: Creating default object from empty value in /home4/sspccco/public_html/pharmafacts.com/plugins/system/J2top.php on line 78
Abuse-Deterrent Opioids — Evaluation and Labeling - PharmaFacts
gototopgototop
If you don't find what you're looking for, please let us know.

Abuse-Deterrent Opioids — Evaluation and Labeling

Abuse-Deterrent Opioids — Evaluation and Labeling

Guidance for Industry

U.S. Department of Health and Human Services Food and Drug Administration
Center for Drug Evaluation and Research (CDER)

Clinical Medical April 2015

page1image3456

 

Abuse-Deterrent Opioids — Evaluation and Labeling

Guidance for Industry

Additional copies are available from:
Office of Communications
Division of Drug Information, WO51, Room 2201
10903 New Hampshire Ave.
Silver Spring, MD 20993-0002
Phone: 301-796-3400; Fax: 301-847-8714 This e-mail address is being protected from spambots. You need JavaScript enabled to view it
http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htm

page2image3576

U.S. Department of Health and Human Services Food and Drug Administration
Center for Drug Evaluation and Research (CDER)

Clinical Medical April 2015

Click HERE for full Guidance